Omega-3 polyunsaturated fatty acids and cardiovascular diseases
Omega-3 polyunsaturated fatty acid (ω-3 PUFA) therapy continues to show great promise in
primary and, particularly in secondary prevention of cardiovascular (CV) diseases. The most …
primary and, particularly in secondary prevention of cardiovascular (CV) diseases. The most …
Familial hypercholesterolaemia: a model of care for Australasia
GF Watts, DR Sullivan, N Poplawski… - Atherosclerosis …, 2011 - Elsevier
Familial hypercholesterolaemia (FH) is a dominantly inherited disorder present from birth
that causes marked elevation in plasma cholesterol and premature coronary heart disease …
that causes marked elevation in plasma cholesterol and premature coronary heart disease …
Encapsulation of fish oil in soybean protein particles by emulsification and spray drying
This manuscript reports a systematic study of encapsulation of fish oil into soybean
microparticles by emulsification and subsequent spray drying in order to protect it from lipid …
microparticles by emulsification and subsequent spray drying in order to protect it from lipid …
[HTML][HTML] Icosapent ethyl, a pure ethyl ester of eicosapentaenoic acid: effects on circulating markers of inflammation from the MARINE and ANCHOR studies
HE Bays, CM Ballantyne, RA Braeckman… - American Journal of …, 2013 - Springer
Background Icosapent ethyl (IPE) is a high-purity prescription form of eicosapentaenoic acid
ethyl ester approved by the US Food and Drug Administration as an adjunct to diet to reduce …
ethyl ester approved by the US Food and Drug Administration as an adjunct to diet to reduce …
Normalizing metabolism in diabetic pregnancy: is it time to target lipids?
HL Barrett, M Dekker Nitert, HD McIntyre… - Diabetes …, 2014 - Am Diabetes Assoc
Outcomes in pregnancies complicated by preexisting diabetes (type 1 and type 2) and
gestational diabetes mellitus have improved, but there is still excess morbidity compared …
gestational diabetes mellitus have improved, but there is still excess morbidity compared …
Methods of reducing the risk of a cardiovascular event in a subject on statin therapy
P Soni - US Patent 9,610,272, 2017 - Google Patents
In various embodiments, the present invention provides methods of reducing the risk of a
cardiovascular event in a subject on statin therapy and, in particular, a method of reducing …
cardiovascular event in a subject on statin therapy and, in particular, a method of reducing …
Recent advances in pharmacotherapy for hypertriglyceridemia
A Sahebkar, GT Chew, GF Watts - Progress in lipid research, 2014 - Elsevier
Elevated plasma triglyceride (TG) concentrations are associated with an increased risk of
atherosclerotic cardiovascular disease (CVD), hepatic steatosis and pancreatitis. Existing …
atherosclerotic cardiovascular disease (CVD), hepatic steatosis and pancreatitis. Existing …
Stable pharmaceutical composition and methods of using same
M Manku - US Patent 8,298,554, 2012 - Google Patents
US8298554B2 - Stable pharmaceutical composition and methods of using same - Google
Patents US8298554B2 - Stable pharmaceutical composition and methods of using same …
Patents US8298554B2 - Stable pharmaceutical composition and methods of using same …
Compositions comprising EPA and obeticholic acid and methods of use thereof
JS Zakrzewski - US Patent 9,814,733, 2017 - Google Patents
US9814733B2 - Compositions comprising EPA and obeticholic acid and methods of use
thereof - Google Patents US9814733B2 - Compositions comprising EPA and obeticholic …
thereof - Google Patents US9814733B2 - Compositions comprising EPA and obeticholic …
Compositions and methods for lowering triglycerides without raising LDL-C levels in a subject on concomitant statin therapy
I Osterloh, P Wicker, R Braeckman, P Soni… - US Patent …, 2013 - Google Patents
US8455472B2 - Compositions and methods for lowering triglycerides without raising LDL-C
levels in a subject on concomitant statin therapy - Google Patents US8455472B2 …
levels in a subject on concomitant statin therapy - Google Patents US8455472B2 …